Mendel Money Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Mendel Money Management's BMY Position: Q2 2026 in Review
Mendel Money Management reduced its Bristol-Myers Squibb (BMY) stake by 31% in Q2 2026, selling an estimated $156K and leaving 5,935 shares worth $342K. The position accounts for 0.13% of the portfolio, ranked #108.
Mendel Money Management first reported a position in BMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $712K in Q1 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Mendel Money Management held 5,935 shares of Bristol-Myers Squibb worth $342K as of Q2 2026.
- Mendel Money Management sold 2,720 Bristol-Myers Squibb shares in Q2 2026, an estimated $156K.
- Bristol-Myers Squibb made up 0.13% of Mendel Money Management's portfolio in Q2 2026, its #108 holding.
- Mendel Money Management first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 18 quarters since.
- Mendel Money Management's Bristol-Myers Squibb position peaked at $712K in Q1 2025.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Mendel Money Management's 13F filing for Q2 2026, filed 30 Jul 2026.